Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1964 1
1969 2
1971 3
1976 1
1978 2
1979 1
1981 2
1982 1
1984 2
1985 7
1986 3
1987 4
1988 5
1989 7
1990 6
1991 2
1992 9
1993 5
1994 13
1995 14
1996 19
1997 13
1998 12
1999 27
2000 18
2001 33
2002 43
2003 27
2004 37
2005 37
2006 31
2007 27
2008 39
2009 38
2010 46
2011 53
2012 60
2013 39
2014 50
2015 36
2016 53
2017 61
2018 42
2019 46
2020 56
2021 60
2022 36
2023 31
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

1,022 results

Results by year

Filters applied: . Clear all
Page 1
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.
Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, Chollet P, Manikas A, Diéras V, Delozier T, Vladimirov V, Cardoso F, Koh H, Bougnoux P, Dutcus CE, Seegobin S, Mir D, Meneses N, Wanders J, Twelves C; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Cortes J, et al. Lancet. 2011 Mar 12;377(9769):914-23. doi: 10.1016/S0140-6736(11)60070-6. Epub 2011 Mar 2. Lancet. 2011. PMID: 21376385 Clinical Trial.
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.
Yoo C, Kim KP, Jeong JH, Kim I, Kang MJ, Cheon J, Kang BW, Ryu H, Lee JS, Kim KW, Abou-Alfa GK, Ryoo BY. Yoo C, et al. Lancet Oncol. 2021 Nov;22(11):1560-1572. doi: 10.1016/S1470-2045(21)00486-1. Epub 2021 Oct 14. Lancet Oncol. 2021. PMID: 34656226 Clinical Trial.
BACKGROUND: The prognosis of patients with advanced biliary tract cancer who have progressed on gemcitabine plus cisplatin is dismal. ...
BACKGROUND: The prognosis of patients with advanced biliary tract cancer who have progressed on gemcitabine plus cisplatin is dismal. …
Lupus nephritis in children.
Moral Larraz A, Cuenca Carcelén S, Aparicio López C, Clemente Garulo D, López Robledillo JC, de Lucas Collantes C. Moral Larraz A, et al. Andes Pediatr. 2021 Jun;92(3):420-427. doi: 10.32641/rchped.v92i3.2960. Andes Pediatr. 2021. PMID: 34479249 Free article. English, Spanish.
Predictors of survival in malignant aortic tumors.
Vacirca A, Faggioli G, Pini R, Freyrie A, Indelicato G, Fenelli C, Bacchi Reggiani ML, Vasuri F, Pasquinelli G, Stella A, Gargiulo M. Vacirca A, et al. J Vasc Surg. 2020 May;71(5):1771-1780. doi: 10.1016/j.jvs.2019.09.030. Epub 2019 Dec 17. J Vasc Surg. 2020. PMID: 31862201 Free article. Review.
Survival at 1 year, 3 years, and 5 years and the possible preoperative and operative outcome predictors were evaluated using Kaplan-Meier analysis with a log-rank test and by Cox regression for multivariate analysis. ...Chronic hypertension (P = .03), fever (P = .03), back …
Survival at 1 year, 3 years, and 5 years and the possible preoperative and operative outcome predictors were evaluated using Kaplan-M …
Transnasal injection laryngoplasty.
Hamdan AL, Ziade G, Jaffal H, Skaff G. Hamdan AL, et al. Ann Otol Rhinol Laryngol. 2015 Jun;124(6):474-9. doi: 10.1177/0003489414567936. Epub 2015 Jan 29. Ann Otol Rhinol Laryngol. 2015. PMID: 25632960
1,022 results